Cathie Wood Medi Wound Ltd. Transaction History

Ark Investment Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 11, 2022	SELL	$1.33 - $2.35 $2,691 - $4,756	-2,024 Closed	0 $0
Q1 2022 Apr 19, 2022	SELL	$1.86 - $3.24 $1.55 Million - $2.7 Million	-832,142 Reduced 99.76%	2,024 $4,000
Q4 2021 Jan 28, 2022	BUY	$2.2 - $4.01 $152,438 - $277,852	69,290 Added 9.06%	834,166 $1.97 Million
Q3 2021 Nov 12, 2021	BUY	$3.34 - $4.63 $2.55 Million - $3.54 Million	764,876 New	764,876 $2.56 Million
Q4 2019 Jan 31, 2020	SELL	$2.72 - $3.15 $354,872 - $410,974	-130,468 Closed	0 $0
Q3 2019 Nov 12, 2019	BUY	$2.58 - $3.97 $88,677 - $136,452	34,371 Added 35.77%	130,468 $417,000
Q2 2019 Jul 30, 2019	BUY	$3.0 - $5.5 $288,291 - $528,533	96,097 New	96,097 $325,000

Ticker MDWD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,735,200
Market Cap $683M
Description
MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel and bio-therapeutic solutions for tissue repair and regeneration. It markets NexoBrid, a biopharmaceutical product for the removal of eschar, a dead or damaged tissue in adults with deep partial- and full-thickness thermal burns to burn centers and hosp...

Get notified when there are updates to the investment portfolio of Ark Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Ark Investment Management LLC and Cathie Wood with notifications on news.